Scientists have created a tiny, beating piece of heart tissue from a patient's own blood cells, offering what researchers say could become a more realistic way to study dilated cardiomyopathy, a serious heart condition that often leads to heart failure. The proof-of-concept study demonstrated that a laboratory-grown "mini-heart" made from cells taken directly from a person with dilated cardiomyopathy (DCM) was able to reproduce key features of the disease, including abnormal and irregular heartbeats. DCM is a condition in which the heart becomes enlarged and weakened, reducing its ability to pump blood effectively throughout the body.
According to the study, the disease carries a 50 percent risk of progressing to heart failure within five years, highlighting the need for better tools to understand how it develops and how it might be treated. Researchers say existing approaches, including animal models and cells grown in laboratory dishes, do not fully capture the complexity of the human heart. To address that challenge, the team turned to a patient's own cells.
Ayesha Bryant, clinical advisor of Alpas Wellness, told Newsweek that patient-derived models could provide researchers with insights that traditional models cannot because they allow scientists to study how a disease behaves within an individual's unique genetic makeup. She said that understanding those interactions may eventually support the development of more personalized treatments. The process began with blood cells collected from an individual diagnosed with DCM.
Scientists reprogrammed those cells into induced pluripotent stem cells, a type of cell capable of developing into many different tissues in the body. The stem cells were then transformed into cardiomyocytes, the specialized muscle cells responsible for generating the heart's contractions. Using those heart muscle cells, the team engineered a three-dimensional heart tissue on a chip.
The tissue was capable of beating and contracting on its own, creating what researchers described as a miniature heart model. What sets the new system apart from earlier approaches is its patient-specific design. Rather than relying on generic cells, the model was built using cells from a person living with DCM, allowing researchers to more closely recreate the biological characteristics of that individual's disease.
The scientists also incorporated tiny fluorescent beads throughout the engineered tissue. These beads acted as tracking markers, enabling researchers to monitor movement and contractions across different regions of the mini-heart during each beat. The approach provided a detailed picture of how the tissue functioned and how different areas responded as it contracted.
Extract — continue reading at the source.
